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Abstract 
Almost 30% of US residents ages 65 and older have diabetes.  The cost of diabetes care was 
estimated at $174 billion in 2007, including $116 billion in additional medical costs, and 
$58 billion in reduced productivity.  Globally, the estimated cost of diabetes care was $376 
billion in 2010, representing 12% of health expenditures. Many individuals with diabetes 
make use of functional foods, nutritional supplements, and/or herbal remedies to manage 
their  disease.    The  functional  foods  olive  leaf  extract,  turmeric,  and  fenugreek  are 
commonly used in traditional medicine systems to manage diabetes.  All three of these 
functional  foods  have  antioxidant  and  anti-inflammatory  properties  as  well  as  specific 
insulin sensitizing qualities.  In vitro studies offer proof of mechanism, and animal studies 
consistently show treatment efficacy for all three foods.  The few human studies that have 
been conducted, however, use surrogate rather than clinical endpoints.  The establishment 
of these and other functional foods as evidence based interventions for diabetes requires 
well designed, adequately powered, and randomized controlled pivotal trials with clinical 
endpoints. 
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Background 
More than one third of all American adults are obese, reflecting an upward prevalence trend 
over the past two decades [1].  This obesity epidemic is associated with an increased risk of 
obesity-associated  morbidity,  including  heart  disease,  stroke,  certain  cancers,  and,  most 
importantly, diabetes [2].  Approximately 26.9% of all US residents aged 65 years and older 
had diabetes in 2010, and an additional 1.9 million individuals aged 20 years and older were 
newly diagnosed with the disease [3].     
Diabetes is no longer a disease of developed nations.  It has been estimated that 6.4% 
of the global adult population, or 285 million individuals, had diabetes in 2010, and that this 
number is expected to increase to 7.7% or 439 million adults worldwide by 2030 [4].  These Functional Foods in Health and Disease 2011, 1(11):472-481                                                  Page 473 of 481  
 
 
estimates represent a 46.3% increase over earlier prevalence estimates for the period ending 
in 2025 [5].  Thus, it is clear that diabetes is a major global public health crisis. 
The cost of diabetes care is staggering, estimated at $174 billion for the year 2007, 
including $116 billion in additional medical costs and $58 billion in reduced productivity 
costs  [3].    Globally,  the  estimated  cost  of  diabetes  care  was  $376  billion  in  2010, 
representing 12% of health care expenditures, and is expected to rise to $490 billion in 2030 
[6].  
In addition to medication, many individuals with diabetes use functional foods and/or 
take nutritional supplements and/or herbal remedies to manage their disease [7, 8].  Some 
functional foods have been extensively studied, including olive leaf extract, turmeric and 
fenugreek.    All  three  of  these  functional  foods  have  been  used  in  traditional  medicine 
systems to manage diabetes [9, 10].   
The present qualitative review is undertaken to examine the pre-clinical and clinical 
evidence regarding the efficacy of each of these functional foods in treating diabetes in 
humans.  
 
OLIVE LEAF EXTRACT 
 
Bioactive properties 
Olive  leaves,  particularly  Olea  europaea  L.,  are  rich  in  phenolic  compounds  including 
flavones, flavonols, catechin, and substituted phenols [11].  The most abundant polyphenol 
in  olive  leaves  is  oleuropein,  which  accounts  for  approximately  20%  of  phenolic 
compounds in the olive leaf, which has been shown to suppress improved insulin secretion 
in H₂O₂-exposed cells [12].  Olive leaf phenolic compounds have been shown to have both 
antioxidant and anti-inflammatory properties [13, 14]. 
        Used in traditional medicine to treat hyperglycemia and diabetes [15], olive leaf extract 
has been shown to improve beta cell viability and protect against cell death after cytokine 
exposure  through  suppression  of  caspase  3/7  activity,  protecting  insulin  secretion,  and 
reducing reactive oxygen species production post exposure [16].  It has been proposed that 
olive  leaf  extract  potentiates  glucose-induced  insulin  release  and  increases  peripheral 
glucose uptake.  
 
Animal Studies 
Olive leaf extract has been shown to reduce hyperglycemia and hyperinsulinemia in sand 
rats fed a high cholesterol [17] or hypercaloric [18] diet.  The oral administration of olive 
leaf extract significantly decreased serum glucose while simultaneously increasing serum 
insulin in streptozotocin-induced diabetic rats, but not controls, an effect described by the 
investigators as more effective than the antidiabetic effect of glibenclamide [19].  
        In  an  alloxan-induced  diabetic  rabbit  model,  oleurpein,  the  most  abundant  active 
phenolic  compound  in  olive  leaf  extract,  was  shown  to  reduce  both  blood  glucose  and 
plasma  malondialdehyde  [MDA]  as  well  as  other  markers  of  oxidative  stress  [20].  
Similarly, in alloxan-induced Wistar rats, oleurpein and hydroxytyrosol, derived from olive 
leaf extract, reduced blood glucose and cholesterol, and normalized the markers of oxidative 
stress [21]. Male Wistar rats fed a high carbohydrate, high fat diet with olive leaf extract did 
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observed in rats fed identical diets without olive leaf extract [22].  Investigators attributed 
these observations to the anti-inflammatory and antioxidant properties of olive leaf extract 
polyphenols, especially oleuropein and hydroxytyrosol.  
 
Human Studies 
Olive leaf extract efficacy has not been widely studied in humans.  In an in vitro study, 
Jurkat cells in culture were exposed to continuously generated hydrogen peroxide. Extracts, 
including olive oil and olive mill waste water, were evaluated for their ability to decrease 
the hydrogen peroxide-induced formation of single strand breaks in the nuclear DNA, and 
the toxic effects were estimated from the increase of DNA damage when the extracts or 
isolated  compounds  were  incubated  directly  with  the  cells.  Significant  protection  was 
observed in extracts from olive oil and olive mill wastewater. However, when olive oil 
extracts had a concentration above 100-mcg/ml, the extracts exerted DNA damaging effects 
by themselves in the absence of any H2O2. Although extracts from olive leaves and olive 
fruits were protective, they were also able to induce DNA damage by themselves [23]. The 
efficacy of olive leaf extract on metabolic, hemodynamic and anthropometric measures was 
studied  in  a  clinical  trial  in  borderline  hypertensive  monozygotic  twins.    A  significant 
reduction in both systolic and diastolic blood pressure was observed, however, differences 
in glucose were not detected [24]. 
In a randomized, double blind clinical trial, 79 adults with type 2 diabetes [T2DM] 
were randomized to treatment with 500 mg of olive leaf extract tablets, taken orally once 
daily or matching the placebo. Subjects treated with olive leaf extract exhibited significantly 
lower  HbA1c,  and  fasting  plasma  insulin  levels;  however,  post  prandial  plasma  insulin 
levels did not differ significantly by treatment group [25]. 
 
TURMERIC 
 
Bioactive properties 
Curcumin, a dietary polyphenol in turmeric, has been shown to exert an anti-adipogenic 
function  in  both  human  and  murine  preadipocytes,  particularly  in  the  early  stages  of 
adipocyte differentiation [26].  A dose-dependent decrease in leptin and lipopolysaccharide-
induced  IL-6  secretion  was  observed  in  adipocytes  incubated  with  curcumin  [27].  
Downregulation  of  other  inflammatory  cytokines  such  as  resistin  and  upregulation  of 
adiponectin  have  also  been  observed  [28].    Through  its  interaction  with  several  signal 
transduction pathways, curcumin can reverse insulin resistance, hyperglycemia, and other 
inflammatory symptoms associated with obesity and metabolic diseases.   Curcumin has 
been shown to inhibit fatty acid synthase, repressing lipid accumulation, down-regulating 
mRNA  levels  of  peroxisome  proliferators-activated  receptor  [PPAR]  γ,  inhibiting  lipid 
accumulation [29].   
MCP-1 upregulates amylin, the most abundant pancreatic islet amyloid component, 
through  ERK1/2/JNK-AP1  and  NF-κB  related  signaling  pathways,  contributing  to  the 
plasma amylin elevation in obesity and insulin resistance [30].  Curcumin has been shown 
to activate the volume-regulated anion channel in murine pancreatic beta cells, enhancing 
insulin release [31].  Additionally, by inducing phase 2 enzyme HO-1 expression, curcumin 
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In addition to curcumin, turmeric contains the water soluble pepetide tumerin, which has 
been  shown  to  have  antioxidant  capacity  and  to  inhibit  α-amylase  and  α-glucosidase 
activity, suggesting possible anti-diabetic treatment potential [33]. 
 
Animal Studies 
The hypoglycemic effect of turmeric and its constituent curcumin has been reported in a 
variety of animal models in association with antioxidant action, and has been attributed to a 
decrease in sorbitol dehydrogenase [34].  Curcumin lowered blood glucose, glycosylated 
hemoglobin,  free  fatty  acids,  total  cholesterol,  triglyceride  and  lipid  peroxidation  levels 
while increasing plasma insulin and hepatic glycokinase activity levels in C57BL/Ks-db/db 
diabetic mice, a model for human T2DM. Hamsters fed a high fat, high cholesterol diet 
treated  with  curcumin  exhibited  a  normalization  of  lipoprotein  profile  together  with  a 
reduction in leptin levels and attenuated insulin resistance [35].   
  In male Sprague Dawley rats with T2DM induced by a high fat diet, curcumin 
reduced  hyperglycemia,  and  improved  insulin  sensitivity  while  concomitantly  reducing 
TNF-α  levels,  implying  an  anti-inflammatory  effect  [36].  Similarly,  dietary  curcumin 
improved glucose tolerance, reduced insulin resistance, increased adipose tissue adiponectin 
production, and decreased pro-inflammatory cytokines including TNF-α, IL-1β, and limited 
white adipose tissue macrophage infiltration in  obese, leptin-deficient ob/ob  C57 BL/6J 
mice [37]. 
  In addition to ameliorating diabetes, turmeric and curcumin have been shown to 
reduce diabetes complications including ophthalmologic, nephrologic and cardiovascular 
complications.  In rats with streptozotocin [STZ] -induced diabetes, turmeric and curcumin 
delayed cataract maturation [38] and reduced renal lesions [39]. In atherosclerotic rabbits 
fed  a  high  fat  diet,  curcumin  reduced  plasma  lipid  peroxides,  increased  antioxidant  α-
tocopherol and coenzyme Q levels, and reversed atherosclerotic damage to the thoracic and 
abdominal aorta [40].    
 
Human Studies 
Few clinical trials of turmeric, curcumin or others of its bioactive components have been 
conducted.  In  a  study  in  healthy  subjects,  the  intake  of  6g/day  turmeric  increased 
postprandial serum insulin levels, while reducing plasma glucose levels [41].  Adults with 
type  2  DM  treated  for  eight-weeks  with  NCB-02,  a  standardized  preparation  of 
curcuminoids,  exhibited  improved  endothelial  dysfunction  associated  with  reductions  in 
inflammatory cytokines and markers of oxidative stress [42]. In adults with type 2 diabetes 
and diabetic nephropathy, short-term turmeric supplementation attenuated proteinuria, TGF-
β and IL-8 [43].   
  
FENUGREEK 
 
Bioactive properties 
Trigonella foenum-graecum (fenugreek) has long been used in traditional medicine systems 
for  its  hypoglycemic  properties  [44],  widely  attributed  to  the  amino  acid  4-
hydroxyisoleucine,  which  has  been  isolated  from  fenugreek  seeds  and  shown  to  have 
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sensitizing  effects,  fenugreek  contains  steroid  saponin  compounds  including  diasgenin, 
alkaloids and trigonelline, which have been shown to inhibit in vitro sodium-dependent 
intestinal glucose uptake and have anti-inflammatory properties [46, 47].  Fenugreek has 
also  been  shown  to  exhibit  dose-dependent  antioxidant  properties,  preventing  lipid 
peroxidation and other oxidative damage in several in vitro models [48-50].  Finally soluble 
dietary  fiber  extracted  from  funugreek  seeds  has  been  shown  to  blunt  serum  glucose 
increase following an oral glucose load associated with decreased intestinal disaccharidase 
activity and glucose absorption together with increased gastrointestinal motility [51].  
 
Animal Studies 
In  alloxan-induced  diabetic  rats,  fenugreek  was  shown  to  have  a  dose-dependent 
hypoglycemic action following a glucose load, associated with increased glucose transport 
rates  [52],  which  may  reflect  increased  induction  of  glucose  transporter  Glut-4 
translocation, enhancing muscle, liver, and adipose cell glucose uptake [53].   
Fenugreek  has  also  been  associated  with  alterations  in  enzymes  associated  with 
carbohydrate  metabolism.    In  diabetic  rat  models,  hepatic  enzymes  associated  with 
glycolysis  including  lactate  dehydrogenase,  pyruvate  kinase,  phosphofructokinase  and 
hexokinas  isozymes  Type  I,  II  and  IV,  are  all  increased  by  fenugreek,  while  hepatic 
enzymes associated with gluconeogenesis are decreased including glucose-6-phosphatase, 
phosphoenolpyruvate carboxykinase and fructose-1,6-bisphosphatase [54-57]. 
 
Human Studies 
Clinical trials of fenugreek for diabetes endpoints have been conducted in humans.  In a 
study of fenugreek treatment efficacy, 60 adults with type 2 diabetes were treated with 25 g 
fenugreek seed powder for 24 weeks, leading to improved measures of glucose homeostasis, 
including reduced urinary gluxose, glycosylated hemoglobin, and area under the curve for 
both glucose and insulin [58].  However, the lack of a parallel control group or placebo 
intervention restricted the generalization of results or determination of causality. 
  A total  of 24 adults  with  type 2 diabetes were treated for eight  weeks  with  10 g 
powdered fenugreek seeds mixed in yoghurt or soaked in hot water.  In an analysis of the 18 
individuals who completed the study, significant reductions in fasting blood sugar were 
observed  in  subjects  treated  with  fenugreek  seeds  soaked  in  hot  water,  but  not  among 
subjects treated with fenugreek seeds mixed with yoghurt [59].  Because the intention-to-
treat analysis was not reported, both internal and external validity are compromised. 
  In  a  double  blind,  placebo-controlled,  cross-over  clinical  trial,  a  wheat  bread 
incorporating fenugreek was tested for metabolic effects and taste acceptability in eight 
individuals with lifestyle-controlled type 2 diabetes.  Subjects were randomized to receive 
56 g bread with 5% fenugreek or regular wheat bread baked at the same bakery. Post-
prandial blood glucose and insulin were measured periodically over a 4-hour period after 
consumption.    Blood  insulin  area  under  the  curve  was  significantly  reduced  following 
consumption of fenugreek-containing bread, and this bread was indistinguishable from the 
whole-wheat control in terms of flavor and appearance [60].  These findings suggest that 
fenugreek may represent an effective food-based means of reducing plasma insulin among 
individuals with type 2 diabetes.                                             
  Fenugreek  seed  extract  has  been  shown  to  reduce  spontaneous  fat  consumption, Functional Foods in Health and Disease 2011, 1(11):472-481                                                  Page 477 of 481  
 
 
leading to a marginal reduction of total energy consumption, in healthy male volunteers 
[61].  Similarly,  in  healthy  overweight  individuals,  fenugreek  seed  extract  significantly 
reduced dietary fat intake and decreased the insulin/glucose ratio [62], however, changes in 
body weight and appetite/satiety scores were not observed. 
  In a meta-analysis of the efficacy of herbal supplements on glucose homeostasis in 
adults with type 2 diabetes, fenugreek was identified as a food associated with significant 
HbA1c  reduction:  -1.13%  [95%  CI  -0.11%--2.14%,  p=0.03].    The  analysis  identified  a 
significant  heterogeneity  of  results,  indicating  the  need  for  well-designed,  randomized, 
placebo-controlled and pivotal clinical trials. 
 
CONCLUSIONS 
In vitro studies have consistently identifyed mechanisms through which olive leaf extract, 
turmeric and fenugreek might exert treatment benefit for individuals with type 2 diabetes.  
All three foods poses antioxidant qualities which can reduce free radical associated tissue 
injury  and  the  formation  of  advanced  glycation  end  products  [AGE],  which  promote 
vascular endothelial cell proliferation, migration, damage, and death [63]. Additionally, all 
three foods have anti-inflammatory properties, which may be of benefit in treating both 
obesity and type 2 diabetes [64].  
Animal studies further demonstrate the potential treatment benefits of these foods.  
Improved glucose homeostasis as well as a normalized lipid profile has been demonstrated 
in a number of animal models.   
Well designed, randomized, placebo-controlled clinical trials aimed at testing the 
efficacy of these foods in treating type 2 diabetes in  humans are scarce.  Such studies, 
adequately powered to detect clinical, rather than only surrogate endpoints, would greatly 
assist in establishing a solid evidence base for the use of these foods in treating type 2 
diabetes.   
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